The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.
暂无分享,去创建一个
P. Pandolfi | L. Kats | J. Teruya-Feldstein | K. Manova-Todorova | U. Ala | Keisuke Ito | M. Jongen‐Lavrencic | S. Sun | S. Song | R. Delwel | Kaitlyn A. Webster | D. Avigan | Lev M. Kats